We are extremely proud to share that MIP Discovery has received significant funding from the Bill and Melinda Gates Foundation for the rapid deployment of novel detection reagents to support mass scale testing in low to middle income countries. mipdiscovery.com/news-2/bill-an…

ow.ly/gaLr50MIJvK MIP Recent funding from the Bill and Melinda Gates Foundation will further accelerate our vision of enabling the rapid deployment of low cost, high volume diagnostic tests to low and middle income countries.

We are delighted to have Dr Brian Burke join the MIP Discovery team as Chief Commercial Officer. Brian brings a wealth of experience in building successful business through technology translation and strategic partnering. mipdiscovery.com/the-management…

With the support of funding from the Bill and Melinda Gates Foundation we will be prepared for the next endemic or pandemic crisis, whether natural or otherwise. Learn more about nanoMIPs for IVD mipdiscovery.com/ivd-assays #IVD #Diagnostics #LateralFlow #Sensors

News: MIP Discovery announces drugs of abuse reagent launch. Read the press release now mipdiscovery.com/drugs-of-abuse…

Our beta Norfentanyl nanoMIP is now available to order from our website. Optimised for sensors, this new affinity reagent has demonstated a limit of detection of under 10ng/ml in a prototype device. Learn more mipdiscovery.com/product/norfen…

Have you visited our new website yet? Head over to mipdiscovery.com to learn more about why we are focused on supporting the next generation of mobile drug testing devices.

Novel nanoMIP affinity reagents engineered to recognise metabolites of the synthetic opioid fentanyl are now available on our website. Learn more #norfentanyl #syntheticopioids #opioidtesting ow.ly/uwYU50NHWL6

Our Head of Chemistry has been discussing the diagnostic capabilities of synthetic affinity reagents over on Laboratory News – Read the full article now labnews.co.uk/article/209329… Laboratory News #MIPs #nanoMIPs #diagnostics #IVD

Fast and effective diagnostic testing is key to disease management but a challenge for antibody-based approaches. Animal free detection reagents present an opportunity for solutions at mass scale, explains Francesco Canfarotta mipdiscovery.com/?post_type=art…

Tomorrow is #NationalFentanylAwarenessDay - Fentanyl is odorless, tasteless, and extremely potent illicit drug - you can’t tell which pills contain a lethal amount. Learn the facts about fentanyl and share them with your friends at fentanylawarenessday.org. National Fentanyl Awareness Day

Fentanyl is involved in more deaths of Americans under 50 than any cause of death, including heart disease, cancer, homicide, suicide and other accidents. Learn more at fentanylawarenessday.org and spread the word to save a life. National Fentanyl Awareness Day

As fentanyl awareness day comes to a close, we encourage everyone to help raise awareness of the dangers of fentanyl abuse, carry naloxone, and know the signs of an overdose. Spread the word to save lives #JustSayKNOW National Fentanyl Awareness Day

Our CCO Brian Burke will be attending the ASGCT meeting in Los Angeles from May 16th - 20th. Drop us a message to schedule a meeting if you would like to learn how nanoMIP affinity reagents can support cell and gene therapy processes. ASGCT #ASGCT23

Are you facing challenges implementing continuous monitoring in your cell and gene therapy processes? nanoMIP based sensing could be the solution - chat with our CCO at ASGCT this week from May 16th – 20th in Los Angeles mipdiscovery.com/cell-and-gene-… #ASGCT23

If we can make synthetic limbs for amputees and scaffolds to regenerate tissues, can we use chemistry to make synthetic affinity reagents? Head to page 18 in the latest edition of Laboratory News to learn more from our our Head of Chemistry cloud.3dissue.com/2153/2844/6246…

Grab a coffee and have a read of our new paper published in Biosensors and Bioelectronics - Electroactive molecularly imprinted polymer nanoparticles for selective glyphosate determination #sensors #biosensors #electrochemicalsensors sciencedirect.com/science/articl…

Our Head of Chemistry has been chatting to Anna MacDonald at Technology Networks on how ‘MIP Discovery are Developing Synthetic Affinity Reagents for Improved Diagnostics’ – Read the new Industry Insights interview now technologynetworks.com/tn/blog/develo…

Learn how MIP Discovery are developing synthetic affinity reagents for improved diagnostics in our Industry Insights interview with Technology Networks technologynetworks.com/tn/blog/develo… #IVD #Diagnostics

MIP Discovery is now Tozaro! ✨Visit us at tozaro.com to see what lies ahead for the rest of 2024 and beyond. We will be retiring this account so be sure to follow us on LinkedIn to stay up to date! linkedin.com/company/tozaro